Jagsonpal Q2 FY27 Revenue Rises 29% to ₹96.4 Crore as Aequitas Deal Opens Hospital Channel
Jagsonpal Pharmaceuticals’ consolidated Q2 FY27 revenue rose 29% to ₹96.4 crore as Aequitas Healthcare was consolidated for the first time, while the company said it expects quarterly revenue to cross ₹100 crore in Q3 after adding Group Pharma’s wellness portfolio.
